Ignite Creation Date:
2024-05-06 @ 2:36 PM
Last Modification Date:
2024-10-26 @ 1:33 PM
Study NCT ID:
NCT04362072
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-27
First Post:
2020-04-22
Brief Title:
Study of Lorlatinib In People With ALK-positive Non-small Cell Lung Cancer
Sponsor:
Organization:
Pfizer